Expanding the Repertoire of Druggable Targets with Angela Koehler

Sponsored by MIT's Technology Licensing Office, the Golden Speaker Series features distinguished members of the MIT community who have been asked to share their academic, research, and tech transfer journeys. This series is a part of MIT's 2024 Independent Activities Period (IAP), a flexible four-week period in January that allows faculty and students to engage in independent study and research, free from the constraints of regular classes.

About the Speaker

Angela Koehler is an Associate Professor in the Department of Biological Engineering at MIT and an intramural member of the David H. Koch Institute for Integrative Cancer Research at MIT. She is also an Institute Member of the Broad Institute and a Founding Member of the MIT Center for Precision Cancer Medicine. Her research group aims to discover and develop functional small-molecule probes of targets emerging from patient-based genomics, including targets deemed recalcitrant to small molecule drug discovery efforts, such as transcription factors, RNA-binding proteins or cytokines. Selected probes may be developed into imaging agents, diagnostic tools, or therapeutic leads.